Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy LumiraDx Limited stock
Learn how to easily invest in LumiraDx Limited stock.
LumiraDx Limited is a diagnostics & research business based in the US. LumiraDx Limited shares (LMDX) are listed on the NASDAQ and all prices are listed in US Dollars. LumiraDx Limited employs 1,513 staff and has a trailing 12-month revenue of around $331.6 million.
How to buy LumiraDx Limited stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – LMDX. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
LumiraDx Limited stock price (NASDAQ: LMDX)Use our graph to track the performance of LMDX stocks over time.
LumiraDx Limited shares at a glance
|Latest market close||$0.98|
|52-week range||$0.77 - $9.43|
|50-day moving average||$1.05|
|200-day moving average||$2.04|
|Wall St. target price||$3.49|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.10|
Buy LumiraDx Limited stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy LumiraDx Limited stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
LumiraDx Limited price performance over time
|1 week (2023-01-26)||11.35%|
|1 month (2023-01-03)||10.10%|
|3 months (2022-11-03)||-5.78%|
|6 months (2022-08-03)||-40.61%|
|1 year (2022-02-03)||-88.98%|
|2 years (2021-01-30)||N/A|
|3 years (2020-01-30)||N/A|
|5 years (2018-01-30)||N/A|
Is LumiraDx Limited stock undervalued or overvalued?
Valuing LumiraDx Limited stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LumiraDx Limited's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LumiraDx Limited's P/E ratio
LumiraDx Limited's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, LumiraDx Limited shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, LumiraDx Limited's P/E ratio is best considered in relation to those of others within the diagnostics & research industry or those of similar companies.
LumiraDx Limited financials
|Revenue TTM||$331.6 million|
|Gross profit TTM||$151.5 million|
|Return on assets TTM||-18.22%|
|Return on equity TTM||-378.14%|
|Market capitalisation||$279.6 million|
TTM: trailing 12 months
LumiraDx Limited share dividends
We're not expecting LumiraDx Limited to pay a dividend over the next 12 months.
LumiraDx Limited overview
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom. .
LumiraDx Limited in the news
LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK
LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
12 Best One Dollar Stocks to Buy According To Hedge Funds
Frequently asked questionsWhat percentage of LumiraDx Limited is owned by insiders or institutions?
Currently 77.614% of LumiraDx Limited shares are held by insiders and 26.684% by institutions. How many people work for LumiraDx Limited?
Latest data suggests 1,513 work at LumiraDx Limited. When does the fiscal year end for LumiraDx Limited?
LumiraDx Limited's fiscal year ends in December. Where is LumiraDx Limited based?
LumiraDx Limited's address is: 3 More London Riverside, London, United Kingdom, SE1 2AQ What is LumiraDx Limited's ISIN number?
LumiraDx Limited's international securities identification number is: KYG5709L1095
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert